Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy

Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy

Saved in:

Bibliographic Details
Main Authors:	Xin-Yu Zhu, Wei-Yi Zhou, Tuo Li
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Military Medical Research
Subjects:	Thyroid-associated ophthalmopathy (TAO) Graves’ ophthalmopathy (GO) Chimeric antigen receptor (CAR)-based therapy
Online Access:	https://doi.org/10.1186/s40779-025-00590-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation of Indonesian Graves’ Ophthalmopathy Quality of Life Questionnaire and Its Association with Clinical Activity and Severity of Graves’ Ophthalmopathy
by: Cecilia Anggraini, et al.
Published: (2024-10-01)

Causal association between non-thyroidal autoimmune diseases and Graves' ophthalmopathy: A mendelian randomization study
by: Lan Ma, et al.
Published: (2025-02-01)

Quality of Life Study in Chronic Diseases: More Needed Than Ever
by: Laurentius Aswin Pramono
Published: (2024-10-01)

Study on the correlation between serum IgG4/IgG levels and the development of Graves’ ophthalmopathy
by: Yuanyuan Deng, et al.
Published: (2025-01-01)

Histogram of Apparent Diffusion Coefficient to Evaluate the Activity of Thyroid‐Associated Ophthalmopathy
by: Defu Li, et al.
Published: (2025-01-01)

Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells
by: Marat Khaliulin, et al.
Published: (2024-11-01)

Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
by: Gohar S. Manzar, et al.
Published: (2025-01-01)

Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
by: Fatemeh Dehghan, et al.
Published: (2025-02-01)

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia
by: P. Joy Ho, et al.
Published: (2025-01-01)

A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
by: Zhao Zhang, et al.
Published: (2025-01-01)

iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
by: Jiepu Zong, et al.
Published: (2025-01-01)

CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
by: Fang Wang, et al.
Published: (2025-02-01)

Unleashing the potential of a low CpG Passer transposon for superior CAR-T cell therapy
by: Jianyao Zeng, et al.
Published: (2025-02-01)

Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
by: Haotian Ma, et al.
Published: (2024-11-01)

Application of adoptive cell therapy in malignant melanoma
by: Qianrong Hu, et al.
Published: (2025-01-01)

Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
by: Narendranath Epperla, et al.
Published: (2025-01-01)

Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024Keypoints
by: Bastian Engel, et al.
Published: (2025-02-01)

Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2025-01-01)

Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2023-05-01)

Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
by: Federica Galvagno, et al.
Published: (2024-11-01)

Cellular therapies in rheumatic and musculoskeletal diseases
by: Pedro Franco-Fuquen, et al.
Published: (2025-06-01)

Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves’ disease
by: Nami Suzuki, et al.
Published: (2025-01-01)

Targeting BCMA in multiple myeloma: designs, challenges, and future directions
by: Yi Hu, et al.
Published: (2025-02-01)

Transition from hypothyroidism to Graves’ disease, development of thyroid eye disease, progression to optic neuropathy after inpatient pulse therapy, and long-term administration of outpatient pulse therapy: a case report with review of literature
by: Koichiro Mizuochi, et al.
Published: (2025-01-01)

Nucleotide receptor P2X7/STAT6 pathway regulates macrophage M2 polarization and its application in CAR-T immunotherapy
by: Qin Si, et al.
Published: (2025-01-01)

Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
by: Anna De Lucia, et al.
Published: (2025-02-01)

Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
by: Jiaying Wu, et al.
Published: (2024-11-01)

Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
by: Yaojun Ren, et al.
Published: (2025-02-01)

A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
by: Abrar Al Jassim, et al.
Published: (2018-05-01)

The relationship between cholesterol levels and thyroid eye disease
by: Caroline Cardo, et al.
Published: (2025-02-01)

Evaluation of common COL2A1 gene variants in Iranian patients suspected with Stickler syndrome type I
by: Fatemeh Abolhasani, et al.
Published: (2025-01-01)

Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01)

CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01)

Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy
by: Ke C, et al.
Published: (2025-02-01)

Incidence and risk factors for Graves’ orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves’ disease: investigation of 1,553 cases with newly diagnosed Graves’ disease and proposal of a predictive score
by: Natsuko Watanabe, et al.
Published: (2023-11-01)

Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration
by: Alice Sýkorová, et al.
Published: (2024-09-01)

The Role of Technical Car Features in Managing and Promoting New Peer-to-Peer Car-Sharing Systems: Insights from Potential Users and Strategic Implications for Service Providers
by: Katarzyna Turoń, et al.
Published: (2025-01-01)

Management of Graves’ upper eyelid retraction (GUER): A review
by: Akruti Desai, et al.
Published: (2025-02-01)

Razstava Čar lesa 2024
by: Jure Žigon, et al.
Published: (2024-06-01)

The effect of vibration therapy on the phonatory function of the larynx and thyroid function in female voice professionals
by: Joanna Golec, et al.
Published: (2024-06-01)